Julie Klapstein, founding CEO of Availity, long-time healthcare executive, and a16z Bio + Health's newest advisory partner, joins Julie Yoo, general partner at a16z Bio + Health.
Together, they delve into Julie Klapstein's rich career journey, which has spanned several decades of progress in healthcare. They also discussed building Availity, her time at MultiPlan, and the network effects undergirding both businesses. Finally, they talk about how AI could impact healthcare—for payors, providers, and the network businesses in between.
Journal Club: Remodeling Oncogenic Transcriptomes with Ben Cravatt and Gene Yeo
Health System Partnerships with Tommy Ibrahim
From the Archives: The Art & Science of Biology's Future with Jennifer Doudna
The Power of a Platform Company with Josh Mandel-Brehm
Culture and Company Building with Sam Corcos
Payments & Payors: Fintech's Role with Kurt Adams
American Optimism with Joe Lonsdale
Going to Market in Healthcare: B2C2B
Advancing the Field of Immunotherapeutics
Healthspan, Lifespan, and the Biology of Aging
Payors and Providers Post-Pandemic
Using AI to Take Bio Farther
Expert AI as a Healthcare Superpower
Cultivated Meat: Challenges, Opportunities, Future
AI is Here. Now What?
Regulatory Trends in Telehealth
Demystifying DC: Opportunities for Collaboration
The Consolidated Drug Channel and Cash-Pay Drugs
Bio x Games: Is a Fun, Therapeutic Game Possible?
Carolyn Bertozzi and Degrading Drugs for Problematic Proteins
Create your
podcast in
minutes
It is Free